Although cancer is not contagious and does not spread as rapidly as the Ebola virus, its status as a chronic disease is relative. Once diagnosed, given the rate at which cancer cells multiply, without treatment, the average survival time for breast cancer patients is only 40 days, while the average survival time for stomach, colorectal, liver, pancreatic, and esophageal cancer patients is only 33 days.

Since the discovery of cancer, from humoral carcinogenesis in 460 BC to today's cellular analysis, it has undergone centuries of development. In order to treat cancer, people have tried every means possible, and the treatment methods are incredibly diverse.

Having withstood the test of time and practice, the three main traditional treatments that have remained and are widely accepted are surgery, radiotherapy, and chemotherapy. Molecular targeted therapy and hyperthermia therapy have also undergone preliminary trials.Photodynamic therapywaitCellular immunotherapy is a leading example and is considered one of the most promising cancer treatment technologies of the 21st century.

Surgery, radiotherapy, and chemotherapy have been the most traditional cancer treatment techniques for over 100 years. However, with the increasing number of patients treated annually, their drawbacks have gradually become apparent. Surgery cannot remove cancer cells that are invisible to the naked eye, and even a tiny, invisible cancer cell that falls off during surgery can rapidly grow, metastasize, and spread to any part of the body.

The side effects of chemotherapy are widely known, and the pain of the treatment process is unbearable for most people. Furthermore, chemotherapy cannot kill...Dormant cancer cellsIt only works on cancer cells in the proliferative phase. Radiotherapy also has significant side effects, and since most tumor cells are scattered and cannot be killed by radiation, the development and research of radiotherapy has reached a dead end.

American biologist Daly once predicted this."If the 20th century was the era of drug therapy, the 21st century will be the era of cell therapy."In order to break through the bottlenecks of the three major therapies and overcome the obstacles in cancer treatment, people have turned their attention to the more humane direction of immunotherapy. Breakthroughs at the cellular level have brought about an innovative revolution in cancer treatment, and immune cell therapy has emerged.

Biological immunotherapyIt is a new and highly effective cancer treatment modality, hailed by the industry as the fourth major cancer treatment method after surgery, radiotherapy, and chemotherapy. It utilizes biotechnology and biological agents to collect immune cells from the patient or their relatives, culture and expand them in vitro, and then reinfuse them into the patient, thereby stimulating and enhancing the body's immune function to achieve the goal of treating cancer.

Cellular immunotherapy is applicable to the treatment of tumors at any stage, and plays different roles in the treatment of patients with cancer at different stages.

An important supplement to traditional therapies

Cellular immunotherapy can be used alone and is also an important supplement to the three traditional therapies. It has a significant killing effect on tumor cells and other tumor cells in the non-proliferative phase. It can eliminate cells that surgery and radiotherapy cannot remove.Microscopic residual fociIt can kill cancer cells that are invisible to the naked eye; it can kill dormant tumor cells that chemotherapy drugs cannot kill, and it can enhance the body's immunity, achieving the effects of long-lasting anti-cancer and preventing tumor metastasis and recurrence.

In comprehensive cancer treatment, biological immunotherapy has become the most crucial measure to ultimately improve the cure rate of cancer.

The significance of biological immunotherapy for patients

Immunotherapy's painless and side-effect-free nature makes it particularly suitable for elderly, frail patients, or those who cannot undergo surgery, radiotherapy, or chemotherapy. Experts recommend incorporating biological cell immunotherapy into the treatment plan as early as possible. If patients undergo cell immunotherapy immediately after completing conventional treatment to eliminate residual tumor cells, the probability of recurrence and metastasis will be significantly reduced.

How to choose the timing of cell immunotherapy

Experts say that cell therapy should typically be administered before chemotherapy, primarily because chemotherapy drugs can cause toxic side effects, significantly reducing the quality of the patient's immune cells. Furthermore, it should begin approximately two weeks after chemotherapy, when the patient's condition is stable.Cell reinfusionCell therapy has a shorter treatment time; a second chemotherapy session can be administered within 7 days of cell reinfusion.

Follow my WeChat Official Account